Profile data is unavailable for this security.
About the company
CRISM Therapeutics Corporation, formerly Amur Minerals Corporation, is a British Virgin Islands-based pharmaceutical company. The Company has developed a drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy. Its lead product, ChemoSeed, is a polymer the size of a grain of rice, administering irinotecan, a generic drug approved to treat brain cancer and can be implanted directly into a tumor or the resection margin following the removal of a tumor, thereby ensuring that effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. It seeks to use ChemoSeed to treat high grade gliomas, a brain tumor with no satisfactory treatment. The Company also offers formulation and consultancy services. It provides assistance and services to improve the bioavailability of poorly soluble drugs. It offers remixers and extruders of various sizes.
- Revenue in GBP (TTM)25.00k
- Net income in GBP-1.49m
- Incorporated2004
- Employees0.00
- LocationCRISM' Therapeutics CorpKingston Chambers,, Road TownPO Box 173TORTOLA 680063Virgin Islands (British)VGB
- Phone+7 4 212755615
- Websitehttps://www.crismtherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kanabo Group PLC | 1.14m | -8.18m | 1.42m | 17.00 | -- | 0.2402 | -- | 1.25 | -0.013 | -0.013 | 0.0018 | 0.0094 | 0.1054 | 16.28 | 43.85 | 67,058.82 | -75.70 | -75.83 | -81.16 | -83.33 | 7.89 | -- | -718.33 | -1,267.35 | 2.72 | -63.43 | 0.0337 | -- | 48.42 | -- | -16.26 | -- | -- | -- |
| BSF Enterprise PLC | 52.84k | -1.11m | 2.31m | 10.00 | -- | 0.8502 | -- | 43.73 | -0.0093 | -0.0093 | 0.0004 | 0.0212 | 0.0163 | 0.9496 | 4.07 | 5,284.00 | -34.25 | -35.35 | -37.51 | -38.06 | -34.37 | -- | -2,107.34 | -4,267.99 | 1.38 | -710.58 | 0.00 | -- | -8.61 | -- | 33.41 | -- | -- | -- |
| Nuformix PLC | 0.00 | -652.59k | 5.27m | 3.00 | -- | 6.73 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -65.61 | -- | -88.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82.08 | -- | -- | -- |
| CRISM' Therapeutics Corp | 25.00k | -1.49m | 7.11m | 0.00 | -- | 4.13 | -- | 284.54 | -0.0458 | -0.0469 | 0.0008 | 0.0333 | 0.012 | -- | 0.0305 | -- | -71.61 | -9.33 | -88.05 | -9.68 | 72.00 | -- | -5,952.00 | -32,053.62 | -- | -- | 0.00 | -- | -- | -- | 69.17 | -- | -41.03 | -- |
| Oxford Biodynamics PLC | 1.10m | -11.15m | 11.80m | 44.00 | -- | 4.82 | -- | 10.78 | -0.0096 | -0.0096 | 0.0008 | 0.0006 | 0.1085 | 2.22 | 1.21 | -- | -110.46 | -70.62 | -148.46 | -89.03 | 47.67 | -- | -1,018.54 | -1,715.57 | 0.8005 | -30.88 | 0.8208 | -- | 72.17 | 19.15 | 3.58 | -- | -11.79 | -- |
| Probiotix Health PLC | 2.22m | -736.00k | 12.26m | 4.00 | -- | 6.85 | -- | 5.52 | -0.005 | -0.005 | 0.0146 | 0.0113 | 1.05 | 18.57 | 3.01 | 555,250.00 | -34.67 | -21.03 | -46.17 | -27.30 | 53.17 | 54.10 | -33.14 | -26.58 | 3.99 | -- | 0.00 | -- | 12.55 | 36.47 | -13.39 | -- | -41.50 | -- |
| CRUSHMETRIC Group Ltd | -100.00bn | -100.00bn | 20.77m | 17.00 | -- | 1.25 | -- | -- | -- | -- | -- | 0.0681 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.027 | -- | 0.0898 | -- | -- | -- | -- | -- | -- | -- |
